Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 4
2005 6
2006 4
2007 17
2008 15
2009 14
2010 12
2011 5
2012 6
2013 7
2014 4
2015 4
2016 11
2017 1
2018 2
2019 1
2021 2
2022 4
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for sheng hou
Search for Saiheng Hou instead (1 results)
In-Depth Characterization of a Pro-Antibody-Drug Conjugate by LC-MS.
Liu B, Guo H, Zhang J, Xue J, Yang Y, Qin T, Xu J, Guo Q, Zhang D, Qian W, Li B, Hou S, Dai J, Guo Y, Wang H. Liu B, et al. Among authors: hou s. Mol Pharm. 2016 Aug 1;13(8):2702-10. doi: 10.1021/acs.molpharmaceut.6b00280. Epub 2016 Jul 21. Mol Pharm. 2016. PMID: 27377124
Molecular architecture of the ErbB2 extracellular domain homodimer.
Hu S, Sun Y, Meng Y, Wang X, Yang W, Fu W, Guo H, Qian W, Hou S, Li B, Rao Z, Lou Z, Guo Y. Hu S, et al. Among authors: hou s. Oncotarget. 2015 Jan 30;6(3):1695-706. doi: 10.18632/oncotarget.2713. Oncotarget. 2015. PMID: 25633808 Free PMC article.
Acid-induced aggregation propensity of nivolumab is dependent on the Fc.
Liu B, Guo H, Xu J, Qin T, Xu L, Zhang J, Guo Q, Zhang D, Qian W, Li B, Dai J, Hou S, Guo Y, Wang H. Liu B, et al. Among authors: hou s. MAbs. 2016 Aug-Sep;8(6):1107-17. doi: 10.1080/19420862.2016.1197443. Epub 2016 Jun 16. MAbs. 2016. PMID: 27310175 Free PMC article.
A Randomized, Double-Blind, Parallel Controlled, Single-Dose Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of the Infliximab Biosimilar CMAB008 and the Reference Product in Healthy Chinese Male Subjects.
Zhou R, Chen Q, Hou S, Guo H, Li J, Qian W, Wang H, Ou L, Chen X, Jiang F, Jia J. Zhou R, et al. Among authors: hou s. Clin Pharmacol Drug Dev. 2022 Sep;11(9):1028-1035. doi: 10.1002/cpdd.1135. Epub 2022 Jul 2. Clin Pharmacol Drug Dev. 2022. PMID: 35778977 Clinical Trial.
113 results